powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1144548967
Mark Mastrodicasa
MD
Pulmonary Disease
Indianapolis,
IN
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (5)
CCN 150010
Hospital
CCN 150084
Hospital
CCN 150153
Hospital
CCN 150157
Hospital
CCN 150181
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
1,420
Beneficiaries
—
Total drug cost
$740K
Distinct drugs
23
Brand share
67.0%
Top prescribed drugs
Albuterol Sulfate
232 claims
Fluticasone/Umeclidin/Vilanter
184 claims
Prednisone
128 claims
Montelukast Sodium
99 claims
Fluticasone/Vilanterol
93 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
632
Unique beneficiaries
—
Total services
814
Distinct HCPCS
20
Medicare payment
$58K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 232 Pulmonary Disease providers in IN — above median (cohort median 828).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$158
Payment records
2
By payment type
Food and Beverage
$158
QUALITY · MIPS · 2024
No data available for this provider in 2024.
